iRadimed Corporation revenue for the last year amounted to 65.56 M USD, the most of which — 25.41 M USD — came from its highest performing source at the moment, Magnetic Resonance Imaging Compatible Patient Vital Signs Monitoring Systems, the year earlier bringing 21.72 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought iRadimed Corporation 52.53 M USD, and the year before that — 43.90 M USD.